Further in vivo studies in male pseudohermaphroditism with gynecomastia due to a testicular 17-ketosteroid reductase defect (compared to a case of testicular feminization).
D015068:17-Ketosteroids; D000293:Adolescent; D000328:Adult; D013734:Androgen-Insensitivity Syndrome / Q000378:metabolism*; D000738:Androsterone / Q000097:blood; D003687:Dehydroepiandrosterone / Q000097:blood; D012734:Disorders of Sex Development / Q000150:complications / Q000201:enzymology / Q000378:metabolism* / Q000473:pathology; D004958:Estradiol / Q000097:blood; D004970:Estrone / Q000097:blood; D005260:Female; D005262:Feminization / Q000378:metabolism; D005938:Glucocorticoids / Q000378:metabolism*; D006177:Gynecomastia / Q000150:complications*; D006801:Humans; D008297:Male; D010088:Oxidoreductases / Q000378:metabolism*; D011627:Puberty; D011863:Radioimmunoassay; D013737:Testis / Q000201:enzymology*; D013739:Testosterone / Q000097:blood / Q000378:metabolism*
D015068:17-Ketosteroids; D005938:Glucocorticoids; D004970:Estrone; D013739:Testosterone; D003687:Dehydroepiandrosterone; D004958:Estradiol; D000738:Androsterone; D010088:Oxidoreductases